Cargando…
Clinical and laboratory features of seven patients with acute myeloid leukemia (AML)-M2/M3 and elevated myeloblasts and abnormal promyelocytes
BACKGROUND: There is limited information on a special subtype of Acute myeloid leukemia (AML) characterized by >20% myeloblasts and >20% abnormal promyelocytes in bone marrow and peripheral blood. OBJECTIVE: The objective of the present investigation was to explore the clinical and laboratory...
Autores principales: | He, GanLin, Wang, ChunYan, Li, QingEn, Tan, Huo, Chen, FuXiong, Huang, ZhenQian, Yu, BaoDan, Zheng, LiXia, Zheng, RunHui, Liu, Dan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4325959/ https://www.ncbi.nlm.nih.gov/pubmed/25678855 http://dx.doi.org/10.1186/s12935-014-0111-y |
Ejemplares similares
-
Pseudo Chediak Higashi-like inclusions in myeloblasts in AML-M2
por: Sharma, Sunita, et al.
Publicado: (2013) -
Immediate early response 3 gene promotes aggressive progression and autophagy of AML by negatively regulating AKT/mTOR
por: Chen, Yimin, et al.
Publicado: (2023) -
Exploring the Metabolic Landscape of AML: From Haematopoietic Stem Cells to Myeloblasts and Leukaemic Stem Cells
por: Mesbahi, Yashar, et al.
Publicado: (2022) -
Decreased SATB1 expression promotes AML cell proliferation through NF-κB activation
por: Luo, Xiaodan, et al.
Publicado: (2019) -
AML1-ETO Inhibits Maturation of Multiple Lymphohematopoietic Lineages and Induces Myeloblast Transformation in Synergy with ICSBP Deficiency
por: Schwieger, Maike, et al.
Publicado: (2002)